Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

So everyone knows that the Phase 2 PEG results will be fantastic. And everyone knows that the Enhanze franchise is signing up big partners with big drugs and Roche will be introducing SQ Mabthera to the US shortly and will almost certainly be introducing SQ Herceptin to the US in the not too distant future and Shire have said that HyQ will be a blockbuster. All generally available public information that has been around for months. We know it, and analysts know it and institutions know it. So why is the share price still only $11. I can't believe that when they formally announce a PFS figure double the existing best figure that the share price will suddenly double or triple because everyone already knows what the results will be. Personally I just don't get it. What am I missing here?